GENKY DRUGSTORES CO., LTD. Consolidated Financial Results
for the Six Months Ended December 20, 2021
[Japanese GAAP]
January 25, 2022
Company name: Genky DrugStores Co., Ltd.
Stock exchange listing: Tokyo Stock Exchange
Code number: 9267
URL: http://www.genkydrugstores.co.jp
Representative: Kenichi Fujinaga, President
Contact: Takeshi Tsunemi, Executive Officer, Treasurer and General Manager, IR Division
Phone: +81-776-67-5240
Scheduled date of filing quarterly securities report: February 2, 2022
Scheduled date of commencing dividend payments: February 25, 2022
Availability of supplementary briefing material on quarterly financial results: Available
Schedule of quarterly financial results briefing session: Scheduled (for institutional investors and analysts)
(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Six Months Ended December 20, 2021 (June 21, 2021 to December 20, 2021)
(1) Consolidated Operating Results | (% indicates changes from the previous corresponding period.) | ||||||||
Net income | |||||||||
Net sales | Operating income | Ordinary income | attributable to owners | ||||||
of parent | |||||||||
Six months ended | Million yen | % | Million yen | % | Million yen | % | Million yen | % | |
December 20, 2021 | 76,241 | － | 2,921 | － | 3,126 | － | 2,132 | － | |
December 20, 2020 | 69,117 | 22.7 | 3,230 | 188.5 | 3,422 | 174.5 | 2,436 | 230.9 |
(Note) Comprehensive income: Six months ended December 20, 2021: ¥2,111 million (－%) Six months ended December 20, 2020: ¥2,445 million (232.1%)
Net income | Diluted net | |
per share | income per share | |
Six months ended | Yen | Yen |
December 20, 2021 | 140.50 | 140.30 |
December 20, 2020 | 160.53 | 160.35 |
(Note) "Accounting Standard for Revenue Recognition" (ASBJ Statement No. 29), etc. has been applied from the beginning of the three months ended September 20, 2021. Therefore, the percentage of changes from the previous corresponding period in actual figures before applying the standard is not presented.
(2) Consolidated Financial Position
Total assets | Net assets | Equity ratio | |
Million yen | Million yen | % | |
As of December 20, 2021 | 92,022 | 34,121 | 37.0 |
As of June 20, 2021 | 90,795 | 32,166 | 35.4 |
(Reference) Equity: As of December 20, 2021: ¥34,087 million As of June 20, 2021: ¥32,144 million
2. Dividends
Annual dividends | |||||
1st | 2nd | 3rd | Year-end | Total | |
quarter-end | quarter-end | quarter-end | |||
Yen | Yen | Yen | Yen | Yen | |
Fiscal 2020 | － | 12.50 | － | 12.50 | 25.00 |
Fiscal 2021 | － | 12.50 | |||
Fiscal 2021 | － | 12.50 | 25.00 | ||
(Forecast) | |||||
(Note) Revision to the forecast for dividends announced most recently: No |
3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 20, 2022 (June 21, 2021 to June 20, 2022)
(% indicates changes from | the previous | fiscal year.) | ||||||||
Net income | Net income | |||||||||
Net sales | Operating income | Ordinary income | attributable to | |||||||
per share | ||||||||||
owners of parent | ||||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | Yen | ||
Full year | 160,000 | － | 6,500 | － | 6,800 | － | 4,720 | － | 310.99 |
(Note) Revision to the financial results forecast announced most recently: No
(Note) "Accounting Standard for Revenue Recognition" (ASBJ Statement No. 29), etc. has been applied from the beginning of the three months ended September 20, 2021, and the forecast is based on this standard. Therefore, the percentage of changes from the previous corresponding period in actual figures before applying the standard is not presented.
Notes:
-
Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting in changes in scope of consolidation): No
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name) - Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: No
- Changes in accounting policies, changes in accounting estimates and retrospective restatement
- Changes in accounting policies due to the revision of accounting standards: Yes
- Changes in accounting policies other than 1) above: No
- Changes in accounting estimates: No
- Retrospective restatement: No
- Total number of issued shares (common stock)
-
Total number of issued shares at the end of the period (including treasury stock): As of December 20, 2021: 15,480,684 shares
As of June 20, 2021: 15,477,484 shares - Total number of treasury stock at the end of the period:
As of December 20, 2021: 300,380 shares
As of June 20, 2021: 300,324 shares
3) Average number of shares during the period:
Six months ended December 20, 2021: 15,177,357 shares
Six months ended December 20, 2020: 15,177,277 shares
*These quarterly financial results are outside the scope of quarterly reviews by a certified public accountant or an audit corporation.
-
Explanation of the proper use of financial results forecast and other notes
The earnings forecasts and other forward-looking statements herein are based on information that is available and certain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ significantly from these forecasts due to a wide range of factors.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Genky DrugStores Co. Ltd. published this content on 25 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2022 06:26:35 UTC.
